3118
J . Org. Chem. 2002, 67, 3118-3119
Sch em e 1
A Novel Rea r r a n gem en t to
1,2,4-Tr ia zolo[1,5-a ]qu in oxa lin es
Alan R. Katritzky,* Tian-Bao Huang, and
Olga V. Denisko
Center for Heterocyclic Compounds,
Department of Chemistry, University of Florida,
Gainesville, Florida 32611-7200
Peter J . Steel†
Department of Chemistry, University of Canterbury,
Christchurch, New Zealand
for the preparation of nitrogen-containing fused hetero-
cyclic systems such as pyrazolo[5,1-b]benzimidazoles8 and
tetrazolo[1,5-e][1,2,5]triazepines.9 We now demonstrate
its applicability to 1,2,4-triazolo[1,5-a]quinoxalines.
Following earlier work,10 we reacted benzyl cinnamate
with N-(benzotriazol-1-ylmethyl)furylimidoyl chloride (2a),
prepared in situ from the corresponding R-benzotriazolyl
amide 1a , in the presence of potassium tert-butoxide and
obtained, along with the expected pyrrole 410 (49%),
2-furyl-4-phenyl-1,2,4-triazolo[1,5-a]quinoxaline (3a ) as
a minor product (2%) (Scheme 1). Structure 3a , assigned
katritzky@chem.ufl.edu
Received October 25, 2001
Abstr a ct: Reactions of benzyl bromide or benzyl cinnamate
with N-(benzotriazol-1-ylmethyl)arylimidoyl chlorides (2a ,b)
in the presence of t-BuOK occur with opening of the
benzotriazole ring affording 1,2,4-triazolo[1,5-a]quinoxalines
(3a ,b). A possible reaction mechanism is discussed.
1
on the basis of H and 13C NMR data,2,4 was confirmed
1,2,4-Triazolo[1,5-a]-pyrazines and -quinoxalines pos-
sess a broad spectrum of physiological and biological
activities, which have attracted much recent attention
from medicinal chemists. Thus, Cecchi et al. showed
1,2,4-triazolo[1,5-a]quinoxalines to be potent benzodiaz-
epine receptor ligands,1 adenosine receptor ligands,2 and
highly selective glycine/NMDA and AMPA receptor an-
tagonists.3
The rather limited synthetic approaches to such poly-
cycles include (i) simultaneous formation of both triazole
and pyrazine heterorings on treatment of 2-aza-1,3-diene-
1,1-dicarbonitriles with hydrazides,4 (ii) pyrazine ring
formation by intramolecular reductive cyclization of 1-(2-
nitroaryl)-2-alkoxycarbonyl-1,2,4-triazoles, themselves pre-
pared in four steps from the corresponding o-nitro-
anilines,1,3,5 (iii) triazole ring formation by acid-induced
intramolecular cyclization of quinoxaline amidine or
formamidoxime,6 and (iv) substituent modification of the
already existing bis(heterocyclic) core system, prelimi-
narily obtained by aforementioned methods.2,6,7
by X-ray crystallography.
Apparently, only one nonaromatic carbon of the origi-
nal benzyl cinnamate molecule is retained in the struc-
ture 3a . From this, we hypothesized that an early step
in the formation of 3a was benzylation of an R-amino
carbanion, formed by deprotonation of the intermediate
N-(benzotriazol-1-ylmethyl)furylimidoyl chloride (2a); this
affords the R-benzylated product of type 5 and potassium
cinnamate. Indeed, treatment of N-(benzotriazol-1-yl-
methyl)aryl(heteroaryl)imidoyl chlorides 2a ,b (prepared
in situ) with the more efficient benzyl group donor, benzyl
bromide, and t-BuOK in THF under reflux smoothly gave
1,2,4-triazolo[1,5-a]quinoxalines 3a ,b in 25-31% yields.
These reactions also proceed at 0 °C, but in lower yields.
Compounds 3a ,b give blue fluorescent spots on TLC
plates under UV irradiation and are easily monitored
during purification by column chromatography. The
structure of compound 3b is assigned by analogy and by
comparison of its NMR data with those of 3a .
The mechanism of the transformation 5 f 3 suggested
in Scheme 2 is speculative. Ring closure of 5 induced by
participation of the benzotriazole N-2 electron lone pair
could give 6, which ring opens to the eight-membered
1,2,4,6-tetrazocane 7. The latter rearranges to the enam-
ine form 8. Further ring closure-ring opening, possibly
via 9, would result in the 4,5-dihydro-1,2,4-triazolo[1,5-
a]quinoxaline 10, which is oxidatively aromatized into
1,2,4-triazolo[1,5-a]quinoxaline 3.
In conclusion, we have shown that benzylation of
N-(benzotriazol-1-ylmethyl)-substituted imidoyl chlorides
under basic conditions induces an unusual rearrange-
ment, accompanied by benzotriazole ring opening, with
Intramolecular benzotriazole ring opening-ring clo-
sure without elimination of nitrogen is a powerful tool
† E-mail (P.J .S.): p.steel@chem.canterbury.ac.nz.
(1) Catarzi, D.; Cecchi, L.; Colotta, V.; Melani, F.; Filacchioni, G.;
Martini, C.; Giusti, L.; Lucacchini, A. J . Med. Chem. 1994, 37, 2846.
(2) Colotta, V.; Cecchi, L.; Catarzi, D.; Filacchioni, G.; Martini, C.;
Tacchi, P.; Lucacchini, A. Eur. J . Med. Chem. 1995, 30, 133.
(3) (a) Catarzi, D.; Colotta, V.; Varano, F.; Cecchi, L.; Filacchioni,
G.; Galli, A.; Costagli, C. J . Med. Chem. 1999, 42, 2478. (b) Catarzi,
D.; Colotta, V.; Varano, F.; Cecchi, L.; Filacchioni, G.; Galli, A.; Costagli,
C.; Carla`, V. J . Med. Chem. 2000, 43, 3824.
(4) Legroux, D.; Schoeni, J .-P.; Pont, C.; Fleury, J .-P. Helv. Chim.
Acta 1987, 70, 187.
(5) Catarzi, D.; Cecchi, L.; Colotta, V.; Filacchioni, G.; Melani, F. J .
Heterocycl. Chem. 1992, 29, 1161.
(6) (a) Cheeseman, G. W. H.; Cookson, R. F. Condensed Pyrazines.
In The Chemistry of Heterocyclic Compounds; Weissberger, A., Taylor,
E. C., Eds.; Wiley: New York, 1979; Vol. 35, Chapter 23, pp 411, 412.
(b) Vogel, M.; Lippmann, E. J . Prakt. Chem. 1989, 331, 75; Chem.
Abstr. 1990, 112, 77110z.
(7) Catarzi, D.; Cecchi, L.; Colotta, V.; Melani, F.; Filacchioni, G.;
Martini, C.; Giusti, L.; Lucacchini, A. Farmaco 1993, 48, 1065; Chem.
Abstr. 1994, 121, 35533v.
(8) Katritzky, A. R.; Wang, Z.; Lang, H.; Steel, P. J . Khim.
Geterotsikl. Soed. 1996, 775.
(9) Katritzky, A. R.; Fan, W.-Q.; Greenhill, J . V.; Steel, P. J . J . Org.
Chem. 1991, 56, 1299.
(10) Katritzky, A. R.; Huang, T.-B.; Voronkov, M. V.; Wang, M.; Kolb,
H. J . Org. Chem. 2000, 65, 8819.
10.1021/jo011028b CCC: $22.00 © 2002 American Chemical Society
Published on Web 04/06/2002